Vicarious Surgical Inc. (RBOT) is a publicly traded Healthcare sector company. As of May 21, 2026, RBOT trades at $1.92 with a market cap of $13.67M and a P/E ratio of 0.00. RBOT moved -3.52% today. Year to date, RBOT is -80.05%; over the trailing twelve months it is -96.02%. Its 52-week range spans $0.27 to $19.00. Analyst consensus is hold with an average price target of $8.75. Rallies surfaces RBOT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Vicarious Surgical Faces NYSE Delisting After Market Cap Drops Below $15M: NYSE suspended trading of Vicarious Surgical’s Class A shares after its 30-day average global market capitalization fell below $15 million, triggering a delisting process. The company expects OTCID quotation under its current trading symbol on March 4 and has ten business days to appeal the delisting determination.
| Metric | Value |
|---|---|
| Price | $1.92 |
| Market Cap | $13.67M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $19.00 |
| 52-Week Low | $0.27 |
| Volume | 53.79K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-63.22M |
| Gross Margin | 0.00% |
5 analysts cover RBOT: 0 strong buy, 2 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is hold. Average price target: $8.75.